Marque de commerce |
Nom générique |
Indication |
État d'avancement du projet |
Présentation reçue |
Date d'émission de la recommandation |
Gynazole.1 |
Butoconazole nitrate |
Vaginal infection |
Complete |
June 30, 2004 |
January 26, 2005 |
NovoMix 30 |
Insulin aspart/insulin aspart protamine |
Diabetes mellitus |
Complete |
October 13, 2005 |
April 26, 2006 |
Fosavance 70/5600 |
Alendronate sodium / cholecalciferol |
Osteoporosis |
Complete |
December 18, 2008 |
June 17, 2009 |
Abilify |
Aripiprazole |
Schizophrenia |
Complete |
November 6, 2009 |
April 27, 2010 |
Abilify |
Aripiprazole |
Depression, Major Depressive Disorder (MDD) |
Complete |
October 1, 2013 |
October 22, 2014 |
Abilify Maintena |
Aripirazole |
Schizophrénie |
Complete |
January 6, 2014 |
December 19, 2014 |
Abilify |
Aripiprazole |
Schizophrenia and Related Psychotic Disorders |
Complete |
March 29, 2011 |
July 18, 2011 |
Abstral |
Fentanyl citrate |
Pain, Cancer (breakthrough) |
Complete |
June 30, 2011 |
December 16, 2011 |
Aclasta |
Zoledronic acid |
|
Complete |
July 20, 2011 |
November 16, 2011 |
Aclasta |
Zoledronic acid |
Osteoporosis, postmenopausal women |
Complete |
November 29, 2007 |
June 25, 2008 |
Actemra |
Tocilizumab |
Arthritis, juvenile idiopathic |
Complete |
January 30, 2012 |
July 19, 2012 |
Actemra |
tocilizumab |
Artérite à cellules géantes (ACG) |
Complete |
September 25, 2017 |
March 27, 2018 |
Actemra |
Tocilizumab |
Arthritis, Rheumatoid |
Complete |
May 27, 2010 |
November 17, 2010 |
Actemra |
Tocilizumab |
Polyarticular juvenile idiopathic arthritis |
Complete |
July 29, 2013 |
March 19, 2014 |
Actemra |
Tocilizumab |
polyarthrite rhumatoïde |
Complete |
March 3, 2014 |
February 19, 2015 |
Actikerall |
Fluorouracil et acide salicylique |
kératose actinique hyperkératosique |
Complete |
August 31, 2016 |
March 22, 2017 |
Adcirca |
Tadalafil |
Pulmonary arterial hypertension |
Complete |
February 5, 2010 |
July 15, 2010 |
Adderall XR |
Mixed amphetamine salts |
Attention deficit hyperactivity disorder |
Complete |
April 13, 2004 |
November 24, 2004 |
Adderall XR |
Mixed amphetamine salts |
Attention deficit hyperactivity disorder |
Complete |
November 29, 2007 |
June 25, 2008 |
Adderall XR |
Mixed amphetamine salts |
Attention deficit hyperactivity disorder |
Withdrawn |
December 15, 2004 |
|
Adempas |
Riociguat |
Pulmonary hypertension, chronic thromboembolic |
Complete |
September 30, 2013 |
July 17, 2014 |
Adempas |
Riociguat |
Hypertension artérielle pulmonaire (groupe 1 OMS) |
Complete |
June 25, 2015 |
December 17, 2015 |
Adlyxine |
lixisénatide |
Diabète sucré de type 2 |
Complete |
May 29, 2017 |
November 23, 2017 |
Admelog |
Insuline lispro |
Diabète sucré, type 1 et 2 |
En attente |
|
|
Advicor |
Niacin/lovastatin |
Hypercholesterolemia and mixed dyslipidemia |
Complete |
October 18, 2005 |
April 26, 2006 |
Aermony RespiClick |
propionate de fluticasone |
L’asthme |
Complete |
October 4, 2017 |
December 19, 2018 |
Zenhale (inhalation aerosol) |
Mometasone furoate and formoterol |
Asthma maintenance (adults, children 12 or older) |
Complete |
February 16, 2011 |
September 28, 2011 |
Afinitor |
Évérolimus |
astrocytoma sous-épendymaire à cellules géantes associé à la sclérose tubéreuse de Bourneville |
Complete |
March 19, 2014 |
April 15, 2015 |
Afinitor |
Everolimus |
renal angiomyolipoma associated with tuberous sclerosis complex (TSC) |
Complete |
March 8, 2013 |
September 25, 2013 |
Akynzeo |
nétupitant / palonosétron |
la prévention des nausées et vomissements associés à la chimiothérapie |
Complete |
December 8, 2017 |
June 20, 2018 |
Aldurazyme |
Laronidase |
Mucopolysarccharidosis 1 (MPS 1), Hurler, Hurler-Scheie, Scheie |
Complete |
February 3, 2005 |
July 14, 2005 |
Aloxi (injection) |
Palonosetron hydrochloride |
Nausea and vomiting (chemotherapy induced) prevention |
Complete |
October 5, 2012 |
May 15, 2013 |
Aloxi (capsule) |
Palonosetron hydrochloride |
Nausea and vomiting (chemotherapy induced) prevention |
Complete |
October 5, 2012 |
April 24, 2013 |
Aloxi (capsule) |
Palonosetron |
palonosétron Indication: Prévention des nausées et vomissements induits par la chimiothérapie |
Withdrawn |
February 6, 2015 |
|
Altace Plus Felodipine |
Ramipril/felodipine extended release |
Hypertension |
Complete |
June 22, 2006 |
November 15, 2006 |
Altace HCT |
Ramipril/hydrochlorothiazide |
Hypertension |
Suspended |
October 26, 2006 |
|
Altace HCT |
Ramipril/hydrochlorothiazide |
Hypertension |
Complete |
March 26, 2007 |
June 14, 2007 |
Alvesco |
Ciclesonide |
asthma |
Complete |
July 24, 2006 |
December 20, 2006 |
Amevive |
Alefacept |
Psoriasis, moderate to severe chronic plaque |
Complete |
February 28, 2006 |
September 27, 2006 |
Amevive |
Alefacept |
Psoriasis, moderate to severe chronic plaque |
Complete |
November 16, 2004 |
May 26, 2005 |
Anoro Ellipta |
Uméclidinium et vilantérol |
Maladie pulmonaire obstructive chronique |
Complete |
February 26, 2014 |
January 15, 2015 |
Apidra |
Insulin glulisine |
Diabetes, Mellitus (Type 1 & 2) |
Complete |
August 29, 2008 |
February 19, 2009 |
Apprilon |
Doxycycline monohydrate |
Rosacea treatment |
Complete |
April 27, 2012 |
March 27, 2013 |
Aptiom |
Acétate d'eslicarbazépine |
Épilepsie, crises partielles |
Complete |
August 15, 2014 |
April 16, 2015 |
Aptivus |
Tipranavir |
HIV infection |
Complete |
December 15, 2005 |
May 17, 2006 |
Arbesda RespiClick |
propionate de fluticasone / xinafoate de salmétérol |
L’asthme |
Complete |
October 4, 2017 |
December 19, 2018 |
Arnuity Ellipta |
Furoate de fluticasone |
Asthme |
Complete |
June 26, 2015 |
December 17, 2015 |
ASMANEX |
Mometasone furoate |
Asthma, (Bronchial) Prophylactic management of steroid responsive |
Complete |
November 10, 2011 |
May 16, 2012 |
Atripla |
Efavirenz, emtricitabine, tenofovir disoproxil fumarate |
HIV |
Complete |
October 30, 2007 |
April 17, 2008 |
Aubagio |
Teriflunomide |
Multiple Sclerosis, relapsing |
Complete |
August 28, 2013 |
June 18, 2014 |
Somatuline Autogel |
Lanreotide acetate |
Acromegaly |
Complete |
February 20, 2007 |
July 19, 2007 |
Avodart |
Dutasteride |
Prostatic hyperplasia, benign |
Complete |
August 24, 2004 |
January 20, 2005 |
Axert |
Almotriptan |
Migraine |
Complete |
December 24, 2003 |
May 27, 2004 |
Azarga |
Brinzolamide and timolol maleate suspension |
Glaucoma and ocular hypertension |
Complete |
August 28, 2009 |
February 18, 2010 |
Azilect |
Rasagiline mesylate |
Parkinson's disease |
Complete |
September 1, 2006 |
March 28, 2007 |
Azilect |
Rasagiline mesylate |
Parkinson’s disease |
Complete |
March 10, 2009 |
|
Banzel |
Rufinamide |
Lennox-Gastaut syndrome; adjunctive treatment of seizures |
Complete |
September 20, 2011 |
March 15, 2012 |
Baraclude |
Entecavir |
Hepatitis B (chronic) |
Complete |
December 12, 2006 |
November 28, 2007 |
Basaglar |
Insuline glargine |
diabète de type 1 ou 2 |
Active |
October 5, 2015 |
April 14, 2016 |
Benlysta |
Belimumab |
Systemic lupus erythematosus |
Complete |
September 19, 2011 |
April 25, 2012 |
Biktarvy |
bictégravir/emtricitabine/ténofovir/alafénamide |
Infection au VIH-1 |
Complete |
April 30, 2018 |
October 25, 2018 |
Inflectra (Produit biologique ultérieur) |
Infliximab |
Maladie de Crohn et colite ulcéreuse |
Complete |
April 12, 2016 |
October 25, 2016 |
Botox |
OnabotulinumtoxinA |
Migraine, chronic |
Complete |
August 15, 2013 |
May 28, 2014 |
Botox |
OnabotulinumtoxinA |
Urinary incontinence |
Complete |
November 25, 2013 |
November 12, 2014 |
Botox |
OnabotulinumtoxinA |
Neurogenic Detrusor Overactivity |
Complete |
January 31, 2012 |
July 19, 2012 |
Botox |
onabotulinumtoxinA |
migraine chronique |
Active |
November 2, 2018 |
|
Ultibro Breezhaler |
Indacatérol/glycopyrronium |
MPOC |
Complete |
February 3, 2014 |
December 19, 2014 |
Brenzys |
Étanercept |
Polyarthrite rhumatoïde, spondylarthrite ankylosante |
Complete |
April 20, 2016 |
October 25, 2016 |
Breo Ellipta |
furoate de fluticasone et vilantérol |
Asthme |
Withdrawn |
May 2, 2018 |
|
Breo Ellipta |
Fluticasone furoate /vilanterol |
Chronic Obstructive Pulmonary Disease (COPD) |
Active |
October 29, 2013 |
August 18, 2014 |
Breo Ellipta |
fluticasone furoate/vilantérol |
MPOC |
Withdrawn |
June 28, 2017 |
|
Breo Ellipta |
Furoate de fluticasone et vilantérol (sous forme de trifénatate) |
Asthme |
Complete |
August 10, 2015 |
February 18, 2016 |
Brilinta |
Ticagrelor |
Thrombotic events in Acute Coronary Syndromes, Prevention |
Complete |
June 1, 2011 |
December 16, 2011 |
Brilinta |
Ticagrelor |
Acute Coronary Syndromes (ACS) |
Cancelled |
June 8, 2010 |
|
Brilinta |
ticagrélor |
Prévention des événements athérothrombotiques avec antécédents d’infarctus du myocarde |
Complete |
February 18, 2016 |
August 25, 2016 |
Brineura |
cerliponase alpha |
Lipofuscinoses ceroïdes neuronales de type 2 |
Active |
July 31, 2018 |
|
Brivlera |
Brivaracétam |
Epilepsie, crises partielles |
Complete |
April 19, 2016 |
|
BuTrans |
Buprenorphine transdermal patch |
Pain, persistent (moderate intensity) |
Complete |
May 9, 2011 |
September 28, 2011 |
BuTrans |
Buprenorphine transdermal patch |
Pain, persistent (moderate intensity) |
Cancelled |
October 15, 2010 |
|
Byetta |
Exenatide |
Diabetes mellitus, Type 2 |
Complete |
August 23, 2011 |
July 19, 2012 |
Bystolic |
Nebivolol |
Hypertension, essential |
Complete |
February 4, 2013 |
July 18, 2013 |
Caduet |
Amlodipine besylate/ atorvastatin calcium |
Hypertension/ Dyslipidemia |
Complete |
December 15, 2005 |
May 17, 2006 |
Campral |
Acamprosate calcium |
Alcohol Abstinence |
Complete |
July 22, 2008 |
|
Campral |
Acamprosate calcium |
Alcohol Abstinence |
Complete |
August 29, 2007 |
March 27, 2008 |
Cayston |
Aztreonam for inhalation solution |
Cystic fibrosis (CF) with chronic pulmonary pseudomonas aeruginosa infections |
Complete |
December 2, 2010 |
July 18, 2011 |
Celsentri |
Maraviroc |
HIV |
Withdrawn |
November 2, 2007 |
|
Celsentri |
Maraviroc |
HIV |
Complete |
May 7, 2008 |
November 12, 2008 |
Celsentri |
Maraviroc |
HIV-1, treatment naïve (adult) |
Complete |
December 8, 2010 |
July 18, 2011 |
Cerdelga |
Éliglustat |
Maladie de Gaucher |
Complete |
January 20, 2017 |
July 26, 2017 |
Champix |
Varenicline tartrate |
Smoking-cessation |
Complete |
March 21, 2007 |
August 16, 2007 |
Cimzia |
Certolizumab pegol |
Arthritis, rheumatoid |
Complete |
September 3, 2009 |
May 27, 2010 |
Cimzia |
certolizumab pégol |
Psoriasis en plaques, de modéré à grave |
En attente |
|
|
Cimzia |
Certolizumab pegol |
Arthritis, psoriatic |
Complete |
September 2, 2014 |
April 17, 2015 |
Cimzia |
Certolizumab pegol |
spondylarthrite ankylosante |
Complete |
June 23, 2014 |
April 17, 2015 |
Cinqair |
reslizumab |
L'asthme éosinophile |
Active |
October 24, 2018 |
|
Cinqair |
Reslizumab |
Asthme à éosinophiles |
Complete |
August 4, 2016 |
March 22, 2017 |
Cipralex |
Escitalopram oxalate |
Depression, Major Depressive Disorder (MDD) |
Withdrawn |
August 3, 2005 |
|
Cipralex |
Escitalopram oxalate |
Depression, Major Depressive Disorder (MDD) |
Complete |
June 8, 2006 |
January 24, 2007 |
Ciprodex |
Ciprofloxacin hydrochloride and dexamethasone otic suspension |
Otitis media with otorrhea & otitis externa, acute |
Complete |
June 11, 2004 |
January 26, 2005 |
Ciprodex |
Ciprofloxacin hydrochloride & dexamethasone otic suspension |
Otitis media with otorrhea & otitis externa, acute |
Complete |
June 15, 2007 |
October 18, 2007 |
Combigan Ophthalmic Solution |
Brimonidine tartrate/timolol maleate |
Glaucoma |
Complete |
December 15, 2003 |
May 27, 2004 |
COMPLERA |
Emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate |
HIV-1 infection in antiretroviral treatment- naïve adults |
Complete |
October 19, 2011 |
April 19, 2012 |
Constella |
Linaclotide |
Syndrome du colon irritable avec constipation |
Complete |
December 17, 2014 |
September 23, 2015 |
Copaxone |
Glatiramer acetate |
Clinically Isolated Syndrome (CIS), suggestive of Multiple Sclerosis |
Complete |
April 29, 2009 |
November 25, 2009 |
Cortiment |
Budesonide |
Colite ulcéreuse |
Complete |
May 24, 2016 |
March 22, 2017 |
Cosentyx |
Secukinumab |
Arthrite psoriasique |
Complete |
February 19, 2016 |
August 23, 2016 |
Cosentyx |
Secukinumab |
Psoriasis, moderate to severe plaque |
Complete |
December 8, 2014 |
October 28, 2015 |
Cosentyx |
Secukinumab |
Spondylarthrite ankylosante |
Complete |
February 19, 2016 |
August 23, 2016 |
Nucynta CR |
Tapentadol |
Pain, moderate to moderately severe |
Complete |
February 1, 2011 |
September 28, 2011 |
Cresemba |
Isavuconazole |
Traitement de l'aspergillose et de la mucormycose invasives |
Active |
November 2, 2018 |
|
Crysvita |
Burosumab |
Traitement de l’hypophosphatémie liée à l’X |
En attente |
|
|
Cubicin |
Daptomycin |
Skin and skin structure infections & bacteremia |
Complete |
March 6, 2008 |
September 24, 2008 |
Cymbalta |
Duloxetine hydrochloride |
Pain, Neuropathic, Diabetic |
Complete |
February 8, 2008 |
August 14, 2008 |
Cymbalta |
Duloxetine hydrochloride |
Depressive, Major Disorder (MDD) |
Complete |
February 8, 2008 |
August 14, 2008 |
Cystadrops |
Cystéamine |
Dépôts cornéens de cristaux de cystine |
Active |
December 10, 2018 |
|
Daklinza |
Daclatasvir |
Hépatite C chronique |
Complete |
February 13, 2015 |
September 21, 2015 |
Daklinza |
daclatasvir |
Hépatite C, chronique |
Complete |
January 6, 2016 |
May 19, 2016 |
Daxas |
Roflumilast |
Chronic obstructive pulmonary disease (COPD) |
Complete |
November 30, 2010 |
July 27, 2011 |
Delstrigo |
doravirine, lamuvidine et fumarate de ténofovir disoproxil |
infection due au VIH-1 |
Active |
November 16, 2018 |
|
Denavir |
Penciclovir |
Herpes labialis (cold sores) |
Complete |
September 20, 2006 |
April 26, 2007 |
Descovy |
Emtricitabine /ténofovir alafénamide |
Infection par le VIH-1 |
Complete |
January 29, 2016 |
August 24, 2016 |
Diacomit |
Stiripentol |
Dravet Syndrome |
Complete |
October 30, 2013 |
October 16, 2014 |
Dificid |
Fidaxomicin |
Clostridium difficile infection |
Complete |
July 10, 2012 |
December 19, 2012 |
Duaklir Genuair |
Aclidinium bromide/formoterol fumarate dihydrate |
Chronic Obstructive Pulmonary Disease (COPD) |
Complete |
April 1, 2015 |
September 18, 2015 |
Duodopa |
Levodopa / carbidopa |
Parkinson's disease |
Complete |
December 19, 2008 |
July 22, 2009 |
Duodopa |
lévodopa/carbidopa (demande de régimes d'assurance médicaments) |
la maladie de Parkinson |
Complete |
February 8, 2018 |
August 22, 2018 |
DuoTrav |
Travoprost and timolol maleate |
Glaucoma |
Complete |
March 24, 2006 |
August 24, 2006 |
Dupixent |
dupilumab |
dermatite atopique |
Complete |
October 27, 2017 |
June 27, 2018 |
Dymista |
Azelastine HCl and fluticasone propionate |
Seasonal allergic rhinitis |
Active |
December 9, 2014 |
June 17, 2015 |
Dysport Therapeutic |
abobotulinumtoxinA |
Dystonie cervicale |
Complete |
January 31, 2017 |
July 26, 2017 |
Dysport Therapeutic |
abobotulinumtoxinA |
spasticité des membres inférieurs |
Complete |
February 7, 2018 |
August 21, 2018 |
Dysport Therapeutic |
abobotulinumtoxinA |
Spasticité des membres supérieurs |
Complete |
April 24, 2017 |
October 24, 2017 |
Ebixa |
Memantine hydrochloride |
Dementia (Alzheimer type), moderate to severe |
Complete |
December 21, 2004 |
November 23, 2005 |
Edarbi |
Azilsartan medoxomil |
Hypertension, essential |
Complete |
March 8, 2013 |
October 17, 2013 |
Edarbyclor |
Azilsartan medoxomil + chlorthalidone |
Hypertension, essential |
Complete |
March 8, 2013 |
October 17, 2013 |
Edurant |
Rilpivirine |
HIV (treatment - naive adult) |
Complete |
July 29, 2011 |
February 15, 2012 |
Effient |
Prasugrel |
Acute Coronary Syndrome (ACS) |
Complete |
December 12, 2011 |
June 14, 2012 |
Effient |
Prasugrel hydrochloride |
Acute Coronary Syndrome (ACS) |
Complete |
May 5, 2010 |
February 16, 2011 |
Egrifta |
Tésamoréline |
Lipodystrophie associée à l’infection par le VIH |
Complete |
March 2, 2016 |
August 24, 2016 |
Elaprase |
Idursulfase |
Mucopolysarccharidosis II (MPS II), Hunter Syndrome |
Complete |
July 13, 2007 |
December 19, 2007 |
Elelyso |
Taliglucérase alfa |
Maladie de Gaucher |
Complete |
August 15, 2014 |
October 28, 2015 |
Eliquis |
Apixaban |
Thromboembolic events, (venous) prevention |
Complete |
December 20, 2011 |
June 14, 2012 |
Eliquis |
Apixaban |
Thromboembolic events prevention, (atrial fibrillation) |
Complete |
September 25, 2012 |
March 20, 2013 |
Eliquis |
Apixaban |
traitement et prévention de la récurrence de l’incident thromboembolique veineux |
Complete |
September 18, 2014 |
May 7, 2015 |
Trelegy Ellipta |
furoate de fluticasone uméclidinium vilantérol |
maladie pulmonaire obstructive chronique (MPOC) |
Complete |
March 1, 2018 |
August 23, 2018 |
Incruse Ellipta |
Umeclidinium |
maladie pulmonaire obstructive chronique (MPOC) |
Complete |
March 4, 2015 |
September 18, 2015 |
Emend |
Aprepitant |
Nausea and Vomiting, Chemotherapy induced |
Complete |
August 29, 2007 |
February 20, 2008 |
Restasis ophthalmic emulsion |
Cyclosporine |
Dry eye disease, Moderate to moderately severe |
Complete |
December 17, 2010 |
July 18, 2011 |
Enablex |
Darifenacin hydrobromide |
Bladder, overactive |
Complete |
April 26, 2006 |
October 19, 2006 |
Enablex |
Darifenacin hydrobromide |
Bladder, overactive |
Complete |
October 1, 2008 |
April 16, 2009 |
Entresto |
sacubitril/valsartan |
insuffisance cardiaque, classe NYHA II or III |
Complete |
September 18, 2015 |
March 18, 2016 |
Entyvio |
Vedolizumab |
Colite ulcéreuse |
Complete |
February 20, 2015 |
October 28, 2015 |
Entyvio |
Védolizumab |
Maladie de Chrohn |
Complete |
April 27, 2016 |
October 27, 2016 |
Epclusa |
Sofosbuvir/ velpatasvir |
Hepatitis C, chronic |
Complete |
April 22, 2016 |
October 26, 2016 |
Erelzi |
étanercept |
Spondylarthrite ankylosante, polyarthrite juvénile idiopathique, polyarthrite rhumatoïde |
Complete |
February 2, 2017 |
July 25, 2017 |
Esbriet |
Pirfenidone |
Pulmonary fibrosis (idiopathic, mild to moderate) |
Complete |
October 5, 2012 |
April 18, 2013 |
Esbriet |
Pirfenidone |
Pulmonary fibrosis (idiopathic, mild to moderate) |
Complete |
August 29, 2014 |
April 15, 2015 |
Eucrisa |
crisaborole |
dermatite atopique |
Active |
May 25, 2018 |
|
Evra |
Norgelestromin/ethinyl estradiol |
Contraceptive, patch |
Complete |
December 19, 2003 |
June 23, 2004 |
Exelon Patch |
Rivastigmine |
Dementia (Alzheimer's type) |
Complete |
December 21, 2007 |
July 23, 2008 |
Exjade |
Deferasirox |
Iron overload |
Complete |
October 26, 2006 |
April 19, 2007 |
Eylea |
Aflibercept |
Dégénérescence maculaire liée à l'âge |
Complete |
November 18, 2013 |
October 20, 2014 |
Eylea |
Aflibercept |
Œdème maculaire secondaire à une occlusion veineuse rétinienne |
Complete |
December 14, 2015 |
July 27, 2016 |
Eylea |
Aflibercept |
œdème maculaire diabétique |
Complete |
September 16, 2014 |
May 7, 2015 |
Eylea |
Aflibercept |
œdème maculaire secondaire à une occlusion de la veine centrale de la rétine |
Complete |
October 17, 2014 |
May 7, 2015 |
Fabrazyme |
Agalsidase beta |
Fabry Disease |
Complete |
December 10, 2004 |
May 18, 2005 |
Fabrazyme |
Agalsidase beta |
Fabry Disease |
Complete |
February 24, 2004 |
November 24, 2004 |
Fampyra |
Fampridine |
Multiple Sclerosis, improve walking disability |
Withdrawn |
November 6, 2014 |
|
Fampyra |
Fampridine |
Multiple Sclerosis, improve walking disability |
Complete |
April 16, 2012 |
November 28, 2012 |
Fasenra |
benralizumab |
Asthme grave, éosinophile |
Active |
October 24, 2018 |
|
Fasenra |
benralizumab |
Asthme grave, éosinophile |
Active |
February 23, 2018 |
August 23, 2018 |
Fentora |
Fentanyl buccal |
Accès douloureux transitoires, adultes cancéreux |
Complete |
July 12, 2016 |
February 21, 2017 |
Ferriprox |
Défériprone |
Surcharge en fer transfusionnelle |
Complete |
September 24, 2015 |
March 18, 2016 |
Fibristal |
Ulipristal acetate |
Uterine fibroids (signs and symptoms) |
Complete |
April 17, 2013 |
November 15, 2013 |
Fibristal |
acétate d’ulipristal |
le traitement des fibromes utérins (signes et symptômes) |
Complete |
June 21, 2017 |
November 22, 2017 |
Finacea |
Azelaic acid |
Rosacea |
Complete |
August 31, 2010 |
February 16, 2011 |
Firazyr |
Icatibant |
angioedème héréditaire |
Complete |
March 4, 2014 |
December 19, 2014 |
Forteo |
Teriparatide (rDNA origin) injection |
Osteoporosis |
Withdrawn |
December 18, 2008 |
|
Forteo |
Teriparatide (rDNA origin) injection |
Osteoporosis (in women), Severe |
Complete |
October 23, 2009 |
March 17, 2010 |
Forteo |
Teriparatide (rDNA origin) injection |
Osteoporosis, glucocorticoid induced |
Complete |
December 18, 2008 |
July 22, 2009 |
Forteo |
Teriparatide (rDNA origin) injection |
Osteoporosis |
Withdrawn |
May 29, 2006 |
|
Forteo |
Teriparatide (rDNA origin) injection |
Osteoporosis |
Complete |
June 8, 2004 |
December 22, 2004 |
Forteo |
Teriparatide (rDNA origin) injection |
Osteoporosis |
Withdrawn |
June 12, 2009 |
|
Forxiga |
Dapagliflozin |
Diabète sucré (Type 2) |
Complete |
April 30, 2015 |
November 20, 2015 |
Forxiga |
dapagliflozine |
diabète de type 2 |
Complete |
September 4, 2015 |
April 27, 2016 |
Fosavance |
Alendronate sodium/cholecalciferol |
Osteoporosis |
Complete |
March 27, 2006 |
September 27, 2006 |
Fosrenol |
Lanthanum carbonate hydrate |
Hyperphosphatemia, end-stage renal disease |
Complete |
June 28, 2007 |
January 30, 2008 |
Fulphila |
pegfilgrastim |
Neutropénie fébrile associée à un cancer non myéloïde |
Active |
November 14, 2018 |
|
Fycompa |
Pérampanel |
Épilepsie, crise tonico-clonique généralisée |
Complete |
November 24, 2015 |
May 18, 2016 |
Fycompa |
Perampanel |
Epilepsy, partial onset seizures |
Complete |
March 8, 2013 |
October 17, 2013 |
Galafold |
migalastat |
Maladie de Fabry |
Complete |
June 9, 2017 |
January 24, 2018 |
Galexos |
Simeprevir |
Hepatitis C, chronic |
Complete |
August 22, 2013 |
June 18, 2014 |
Gelnique |
Oxybutynin Chloride Gel |
Bladder, overactive |
Complete |
October 25, 2011 |
May 24, 2012 |
Genotropin |
Somatropin |
Turner Syndrome |
Complete |
May 27, 2013 |
December 20, 2013 |
Genotropin |
Somatropin |
Growth hormone deficiency, adult |
Complete |
May 27, 2013 |
December 20, 2013 |
Genotropin |
Somatropin |
Growth hormone deficiency, pediatric |
Complete |
May 27, 2013 |
December 20, 2013 |
Tudorza Genuair |
Aclidinium bromide |
Chronic Obstructive Pulmonary Disease (COPD) |
Complete |
August 21, 2013 |
April 21, 2014 |
Genvoya |
Elvitégravir/cobicistat/emtricitabine/ténofovir alafénamide |
Infection au VIH |
Complete |
September 24, 2015 |
March 18, 2016 |
Gilenya |
Fingolimod |
Multiple Sclerosis |
Complete |
May 10, 2011 |
November 16, 2011 |
Glatect |
Acétate de glatiramer |
Sclérose en plaques cyclique |
Complete |
January 20, 2017 |
July 25, 2017 |
Grastek |
Phleum pratense |
Allergy (grass) |
Complete |
September 30, 2013 |
September 24, 2014 |
Grastofil |
Filgrastim |
Prévention ou traitement de la neutropénie sous diverses indications |
Complete |
September 11, 2015 |
March 18, 2016 |
Harvoni |
Ledipasvir / sofosbuvir |
hépatite C chronique |
Complete |
September 15, 2014 |
March 18, 2015 |
Harvoni |
lédipasvir, sofosbuvir |
Hépatite C, chronique |
Complete |
January 6, 2016 |
May 18, 2016 |
Hemangiol |
Propranolol |
Infantile hemangioma |
Withdrawn |
December 23, 2014 |
|
Hemangiol |
Solution orale de propranolol |
Hémangiome infantile |
Complete |
August 25, 2016 |
February 21, 2017 |
Hepsera |
Adefovir dipivoxil |
Hepatitis B |
Complete |
June 29, 2007 |
October 18, 2007 |
Hepsera |
Adefovir dipivoxil |
Hepatitis B |
Complete |
April 24, 2006 |
November 29, 2006 |
Holkira Pak |
ombitasvir/paritaprévir/ritonavir et dasabuvir |
Hépatite C, chronique |
Complete |
January 6, 2016 |
May 26, 2016 |
Holkira Pak |
Ombitasvir/paritaprévir/ritonavir and dasabuvir |
Hépathite C chronique |
Complete |
December 3, 2014 |
June 18, 2015 |
Humira |
Adalimumab |
Hidrosadénite suppurée |
Complete |
November 3, 2015 |
May 19, 2016 |
Humira |
Adalimumab |
Arthritis, Rheumatoid |
Complete |
September 24, 2004 |
February 11, 2005 |
Humira |
Adalimumab |
Ankylosing spondylitis (AS) |
Complete |
November 17, 2006 |
June 27, 2007 |
Humira |
Adalimumab |
Crohn's disease |
Complete |
July 12, 2007 |
December 19, 2007 |
Humira |
Adalimumab |
Arthritis, Juvenile Idiopathic |
Complete |
February 4, 2013 |
July 18, 2013 |
Humira |
Adalimumab |
Arthritis, Psoriatic |
Complete |
June 21, 2006 |
November 29, 2006 |
Humira |
Adalimumab |
Psoriasis |
Complete |
April 15, 2008 |
October 16, 2008 |
Humira |
Adalimumab |
Colite ulcéreuse |
Complete |
September 25, 2015 |
April 15, 2016 |
Humira |
Adalimumab |
Ulcerative colitis |
Withdrawn |
December 23, 2013 |
|
Simponi I.V. |
Golimumab |
Arthritis, Rheumatoid |
Complete |
September 12, 2013 |
July 17, 2014 |
Ikervis |
cyclosporine |
Kératite sévère |
Withdrawn |
May 15, 2017 |
|
Ilaris |
Canakinumab |
Cryopyrin-Associated Periodic Syndrome (CAPS) |
Complete |
July 7, 2010 |
January 26, 2011 |
Ilaris |
Canakinumab |
Arthrite idiopathique juvénile systémique |
Complete |
December 23, 2015 |
June 17, 2016 |
Iluvien |
fluocinolone acétonide |
œdème maculaire diabétique |
Withdrawn |
December 21, 2017 |
|
Incivek |
Telaprevir |
Hepatitis C infection (genotype 1), Chronic |
Complete |
August 23, 2011 |
February 15, 2012 |
Incivek |
Telaprevir |
|
Complete |
December 21, 2012 |
June 13, 2013 |
Incivek |
Telaprevir |
Hepatitis C infection, chronic |
Complete |
February 19, 2013 |
June 13, 2013 |
Inflectra |
Infliximab |
Ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis |
Complete |
June 17, 2014 |
December 19, 2014 |
Inspiolto Respimat |
Tiotropium / olodatérol |
Maladie pulmonaire obstructive chronique (MPOC) (COPD) |
Complete |
June 4, 2015 |
December 17, 2015 |
Inspra |
Eplerenone |
Post myocardial infarction |
Complete |
May 6, 2009 |
November 25, 2009 |
Inspra |
Eplerenone |
Heart failure, NYHA class II |
Complete |
July 12, 2013 |
April 24, 2014 |
Intelence |
Etravirine |
HIV |
Complete |
April 2, 2008 |
August 14, 2008 |
Intuniv XR |
Guanfacine hydrochloride |
Attention deficit hyperactivity disorder (ADHD) |
Complete |
August 27, 2013 |
September 24, 2014 |
Invega |
Paliperidone |
Schizophrenia |
Complete |
November 1, 2007 |
May 28, 2008 |
Invega Sustenna |
Paliperidone palmitate |
Schizophrenia |
Complete |
July 9, 2010 |
April 25, 2011 |
Invokamet |
Canagliflozine et metformine |
Diabète de type 2 |
Complete |
March 3, 2016 |
August 25, 2016 |
Invokana |
Canagliflozin |
Diabetes mellitus, type 2 |
Withdrawn |
June 5, 2013 |
|
Invokana |
Canagliflozine |
Diabète de type 2 |
Complete |
February 24, 2014 |
January 15, 2015 |
Iressa |
Gefitinib |
Cancer, Lung , non-small cell |
Complete |
December 22, 2003 |
June 23, 2004 |
Isentress |
Raltegravir |
HIV |
Complete |
November 29, 2007 |
May 14, 2008 |
Isentress |
Raltegravir |
HIV (treatment naïve) |
Complete |
December 4, 2009 |
June 23, 2010 |
Izba |
solution ophtalmique travoprost |
Glaucoma à angle ouvert |
Complete |
March 1, 2017 |
October 25, 2017 |
Janumet |
Sitagliptin phosphate monohydrate / metformin hydrochloride |
Diabetes mellitus (Type 2) |
Complete |
November 4, 2009 |
June 23, 2010 |
Januvia |
Sitagliptin phosphate |
Diabetes mellitus (Type 2) |
Complete |
October 29, 2009 |
June 23, 2010 |
Januvia |
Sitagliptin phosphate |
Diabetes mellitus (Type 2) |
Complete |
December 20, 2007 |
June 18, 2008 |
Jardiance |
Empagliflozin |
Diabète sucré type 2 à haut risque cardiovasculaire |
Complete |
April 27, 2016 |
October 26, 2016 |
Jardiance |
Empagliflozine |
Diabète sucré de type 2 |
Complete |
April 23, 2015 |
October 15, 2015 |
Jentadueto |
Linagliptin-metformin |
Diabetes mellitus (Type 2) |
Complete |
March 8, 2013 |
October 17, 2013 |
Jetrea |
Ocriplasmin |
Vitreomacular adhesion |
Complete |
June 6, 2013 |
December 20, 2013 |
Jinarc |
Tolvaptan |
polykystose rénale à caractère autosomique dominant (ADPKD) |
Complete |
May 29, 2015 |
February 24, 2016 |
Jublia |
éfinaconazole |
Onychomycose |
Active |
August 2, 2018 |
|
Juluca |
Dolutégravir rilpivirine |
Infection par le VIH |
Complete |
December 21, 2017 |
June 20, 2018 |
Jurnista |
Hydromorphone hydrochloride |
Pain, Chronic (moderate to severe) |
Complete |
December 4, 2009 |
May 19, 2010 |
Juxtapid |
Lomitapide |
hypercholestérolémie familiale |
Complete |
July 8, 2014 |
April 17, 2015 |
Kalydeco |
Ivacaftor |
Cystic Fibrosis, R117H CFTR gating mutation |
Complete |
May 8, 2015 |
November 19, 2015 |
Kalydeco |
Ivacaftor |
Cystic Fibrosis patients (G551D mutation) |
Complete |
September 27, 2012 |
March 22, 2013 |
Kalydeco |
Ivacaftor |
Fibrose cystique (mutations de CFTR) |
Complete |
May 1, 2014 |
December 19, 2014 |
Kanuma |
sebelipase alfa |
Déficit en lipase acide lysosomique |
Complete |
November 2, 2017 |
September 26, 2018 |
Kazano |
Alogliptine alliée à metformine |
diabète de type 2 |
Complete |
January 30, 2014 |
January 15, 2015 |
Kevzara |
sarilumab |
Polyarthrite rhumatoïde |
Complete |
October 12, 2016 |
April 18, 2017 |
Kivexa |
Abacavir/lamivudine |
HIV infection |
Complete |
July 26, 2005 |
December 7, 2005 |
Komboglyze |
Saxagliptin + metformin |
Diabetes Mellitus, Type 2 |
Complete |
August 23, 2013 |
June 20, 2014 |
Komboglyze |
Saxagliptin + metformin |
Diabetes Mellitus, Type 2 |
Withdrawn |
June 6, 2013 |
|
Kuvan |
Sapropterin dihydrochloride |
Phenylketonuria (PKU). |
Complete |
July 8, 2010 |
January 26, 2011 |
Kuvan |
Sapropterin dihydrochloride |
Phénylcénoturie (PcU) |
Complete |
February 1, 2016 |
October 26, 2016 |
Kuvan |
Sapropterin dihydrochloride |
Phenylketonuria (PKU). |
Complete |
June 1, 2011 |
|
Kynmobi |
chlorhydrate d'apomorphine |
Maladie de Parkinson |
En attente |
|
|
Lancora |
Ivabradine |
Insuffisance cardiaque, classes NYHA II à III |
Complete |
November 8, 2016 |
May 24, 2017 |
Lantus |
Insulin glargine (rDNA origin) |
Diabetes mellitus, Type 1 & 2 |
Complete |
February 11, 2005 |
September 28, 2005 |
Lantus |
Insulin glargine (rDNA origin) |
Diabetes mellitus, Type 1 & 2 |
Complete |
March 27, 2006 |
October 25, 2006 |
Lantus |
Insulin glargine (rDNA origin) |
Diabetes mellitus, Type 1 & 2 |
Complete |
June 9, 2009 |
|
Lapelga |
Pegfilgrastim |
Neutropénie fébrile |
Complete |
February 23, 2018 |
|
Latuda |
Lurasidone |
schizophrenia |
Complete |
July 3, 2012 |
January 23, 2013 |
Latuda |
Lurasidone |
Schizophrenia |
Complete |
May 9, 2013 |
December 20, 2013 |
Lemtrada |
Alemtuzumab |
Multiple Sclerosis, relapsing |
Withdrawn |
October 1, 2013 |
|
Lemtrada |
Alemtuzumab |
sclérose en plaques cyclique |
Complete |
November 27, 2014 |
June 18, 2015 |
Levemir |
Insulin detemir |
Diabetes mellitus |
Complete |
March 10, 2009 |
August 20, 2009 |
Levemir |
Insulin detemir |
Diabetes mellitus |
Withdrawn |
February 2, 2009 |
|
Levemir |
Insulin detemir |
Diabetes mellitus |
Complete |
December 19, 2005 |
August 2, 2006 |
Levemir |
Insulin detemir |
Diabetes mellitus Type1, Pediatrics |
Complete |
March 10, 2009 |
August 20, 2009 |
Lixiana NVAF |
Edoxaban |
Fibrillation auriculaire non valvulaire, prévention des accidents vasculaires cérébraux et des embolies systémiques |
Complete |
September 9, 2016 |
March 21, 2017 |
Lixiana VTE |
Edoxaban |
Thromboembolie veineuse, traitement et prevention de récurrence |
Complete |
September 9, 2016 |
May 25, 2017 |
Lodalis |
Colesevelam hydrochloride |
Hypercholesterolemia |
Complete |
April 27, 2012 |
December 19, 2012 |
Lotemax |
Loteprednol etabonate |
Post-operative inflammation following cataract surgery |
Complete |
December 2, 2009 |
May 19, 2010 |
Lucentis |
Ranibizumab |
Macular degeneration, age-related |
Complete |
July 12, 2007 |
March 27, 2008 |
Lucentis |
Ranibizumab injection |
Macular edema, secondary to retinal vein occlusion |
Complete |
April 25, 2012 |
October 18, 2012 |
Lucentis |
Ranibizumab |
néovascularisation choroïdienne due à la myopie |
Complete |
February 28, 2014 |
February 19, 2015 |
Lucentis |
Ranibizumab |
Macular edema, diabetic |
Complete |
September 14, 2011 |
March 19, 2012 |
Lyrica |
Pregabalin |
Pain, Neuropathic |
Complete |
June 27, 2005 |
January 25, 2006 |
Lyrica |
Pregabalin |
diabetic peripheral neuropathy |
Complete |
March 20, 2009 |
September 23, 2009 |
Pantoloc M |
Pantoprazole magnesium |
Gastric acid secretion, reduction of |
Complete |
March 17, 2006 |
July 20, 2006 |
Macugen |
Pegaptanib sodium |
Macular degeneration, age-related |
Complete |
October 20, 2005 |
May 25, 2006 |
Mavenclad |
cladribine |
Sclérose en plaques cyclique |
Complete |
December 1, 2017 |
October 24, 2018 |
Maviret |
glécaprévir pibrentasvir |
Hépatite C chronique |
Complete |
June 9, 2017 |
January 23, 2018 |
MDK-Nitisinone |
nitisinone |
la tyrosinémie héréditaire de type 1 |
Complete |
September 29, 2017 |
April 25, 2018 |
Mictoryl |
chlorhydrate de propivérine |
Vessie hyperactive |
Complete |
October 14, 2016 |
April 19, 2017 |
Mifegymiso |
Mifépristone et misoprostol |
Interruption médicale de grossesse |
Complete |
October 7, 2016 |
April 18, 2017 |
Mifégymiso |
Mifépristone et misoprostol |
Interruption médicale de la grossesse (âge gestationnel jusqu’éa 49 jours) |
Withdrawn |
February 12, 2016 |
|
mirabégron |
Myrbetriq |
Vessie hyperactive |
Complete |
November 27, 2013 |
November 12, 2014 |
Monoprost |
latanoprost |
glaucome et hypertension oculaire |
Complete |
October 25, 2017 |
April 24, 2018 |
Movapo |
chlorhydrate d’apomorphine |
Maladie de Parkinson |
Complete |
July 6, 2017 |
January 23, 2018 |
Mozobil |
Plerixafor |
Hematopoietic stem cell mobilizer in non-Hodgkin's lymphoma and multiple myeloma |
Complete |
January 24, 2012 |
September 26, 2012 |
Multaq |
Dronedarone hydrochloride |
Atrial fibrillation |
Complete |
September 18, 2009 |
May 27, 2010 |
Myfortic |
Mycophenolate sodium |
Organ rejection in allogeneic renal transplants, Prophylaxis |
Complete |
March 3, 2005 |
July 8, 2005 |
Myozyme |
Alglucosidase |
Pompe’s disease |
Complete |
October 10, 2006 |
June 14, 2007 |
Myrbetriq |
Mirabegron |
Bladder, Overactive |
Withdrawn |
March 8, 2013 |
|
Naglazyme |
Galsulfase (Drug Plan Submission) |
mucopolysaccharidose de type VI |
Complete |
August 20, 2015 |
February 19, 2016 |
Nesina |
Alogliptine |
diabète de type 2 |
Complete |
January 30, 2014 |
January 15, 2015 |
Neulasta |
Pegfilgrastim |
Neutropenia |
Complete |
March 29, 2004 |
October 27, 2004 |
Neupro |
Rotigotine |
Parkinson’s Disease |
Complete |
July 31, 2013 |
May 28, 2014 |
Neupro |
Rotigotine |
Maladie de Parkinson |
Complete |
May 21, 2015 |
November 19, 2015 |
Nexavar |
Sorafenib tablets |
Cancer, Renal cell carcinoma |
Complete |
July 31, 2006 |
February 28, 2007 |
Nitisinone |
Nitisinone |
Tyrosinémie de type 1 |
Complete |
January 25, 2018 |
August 23, 2018 |
Norprolac |
Quinagolide hydrochloride |
Hyperprolactinemia |
Complete |
December 16, 2004 |
September 28, 2005 |
Norprolac |
Quinagolide hydrochloride |
Hyperprolactinemia |
Complete |
November 23, 2005 |
May 17, 2006 |
Nplate |
Romiplostim |
Chronic immune (idiopathic) thrombocytopenic purpura (ITP) |
Complete |
September 29, 2009 |
May 27, 2010 |
Nucala |
mépolizumab |
L'asthme éosinophile grave |
Active |
October 24, 2018 |
|
Nucala |
Mépolizumab |
Asthme, grave à éosinophiles |
Complete |
December 18, 2015 |
June 16, 2016 |
Nucynta |
chlorhydrate de tapentadol |
douleur intense |
Complete |
April 17, 2018 |
October 23, 2018 |
NuvaRing |
Etonogestrel/ethinyl estradiol |
Contraceptive, ring |
Complete |
May 5, 2006 |
November 29, 2006 |
Ocaliva |
Acide obéticholique |
Cholangite biliaire primitive |
Complete |
December 22, 2016 |
July 25, 2017 |
Ocrevus |
ocrélizumab |
Forme progressive primaire de sclérose en plaques |
Complete |
October 26, 2017 |
April 26, 2018 |
Ocrevus |
ocrélizumab |
sclérose en plaques cyclique |
Complete |
May 16, 2017 |
November 21, 2017 |
Odefsey |
emtricitabine/rilpivirine/ tenofovir alafenamide |
Infection VIH-1 |
Complete |
November 24, 2016 |
May 25, 2017 |
Ofev |
Nintedanib |
Idiopathic pulmonary fibrosis (IPF) |
Complete |
April 23, 2015 |
October 15, 2015 |
Olmetec Plus |
Olmesartan medoxomil + hydrochlorothiazide |
Hypertension |
Complete |
November 28, 2008 |
May 27, 2009 |
Olmetec |
Olmesartan medoxomil |
Hypertension |
Complete |
November 28, 2008 |
May 27, 2009 |
Olumiant |
baricitinib |
Polyarthrite rhumatoïde |
Active |
December 20, 2018 |
|
Omnaris |
Ciclesonide nasal spray |
Allergic Rhinitis (seasonal and perennial) |
Complete |
May 7, 2008 |
November 12, 2008 |
Omnitrope |
Somatropin (rDNA origin) |
Growth hormone deficiency in children and adults |
Complete |
June 12, 2009 |
|
Onbrez |
Indacaterol |
Chronic Obstructive Pulmonary Disease (COPD), maintenance bronchodilator treatment |
Complete |
February 29, 2012 |
August 16, 2012 |
Onglyza |
Saxagliptin |
Diabetes mellitus (Type 2) |
Complete |
November 9, 2009 |
June 17, 2010 |
Onglyza |
Saxagliptin |
Diabetes mellitus (Type 2) |
Complete |
May 9, 2013 |
November 15, 2013 |
Onglyza |
Saxagliptin |
Diabetes mellitus (Type 2) |
Withdrawn |
May 28, 2012 |
|
Onpattro |
patisiran |
La polyneuropathie dans l’amylose héréditaire à transthyrétine |
Active |
January 25, 2019 |
|
Onsolis |
Fentanyl Citrate |
Pain (breakthrough), cancer (adults) |
Withdrawn |
May 10, 2011 |
|
Onsolis |
Fentanyl Citrate |
Pain (breakthrough), cancer (adults) |
Complete |
August 22, 2011 |
February 15, 2012 |
Opsumit |
Macitentan |
Pulmonary arterial hypertension |
Complete |
December 18, 2015 |
January 28, 2015 |
Oralair |
Grass Pollen Allergen Extract |
Allergic rhinitis (grass pollen) |
Complete |
September 21, 2012 |
March 20, 2013 |
Orencia |
Abatacept |
Arthritis, Juvenile Idiopathic & Juvenile Rheumatoid |
Complete |
August 29, 2008 |
April 22, 2009 |
Orencia |
Abatacept |
Arthritis, Rheumatoid |
Complete |
November 29, 2012 |
July 18, 2013 |
Orencia |
Abatacept |
Arthritis, Rheumatoid |
Complete |
December 2, 2009 |
June 17, 2010 |
Orencia |
Abatacept |
Arthritis, Rheumatoid |
Complete |
October 26, 2006 |
June 27, 2007 |
Orfadin |
nitisinone |
la tyrosinémie héréditaire de type 1 |
Complete |
August 29, 2017 |
February 21, 2018 |
Orkambi |
lumacaftor/ivacaftor |
Fibrose kystique, mutation CFTR F508del |
Complete |
January 28, 2016 |
October 26, 2016 |
Orkambi |
lumacaftor/ivacaftor |
Fibrose kystique, mutation F.508del chez les patients âgés de 6 ans et plus |
Complete |
February 22, 2018 |
September 26, 2018 |
Otezla |
Apremilast |
Arthrite, psoriatique |
Complete |
June 8, 2015 |
December 17, 2015 |
Otezla |
Apremilast |
Psoriasis, en plaques modérées à sévères |
Complete |
October 8, 2014 |
July 22, 2015 |
Otezla |
Aprémilast |
Psoriasis, modéré à sévère |
Complete |
March 3, 2016 |
October 26, 2016 |
Ozanex |
ozénoxacine |
Impétigo |
Complete |
January 25, 2018 |
October 24, 2018 |
Ozempic |
Sémaglutide |
Diabète de type 2 |
Active |
November 23, 2018 |
|
Ozurdex |
dexaméthasone |
Œdème maculaire diabétique |
Complete |
September 26, 2017 |
October 24, 2018 |
Ozurdex |
Dexamethasone intravitreal implant |
Macular edema following central retinal vein occlusion |
Complete |
September 1, 2011 |
April 25, 2012 |
Pegasys RBV |
Peginterferon alfa-2a and Ribavirin |
Hepatitis C, chronic |
Complete |
May 14, 2004 |
October 14, 2004 |
Pheburane |
Phénylbutyrate de sodium |
Urea cycle disorders |
Complete |
October 20, 2015 |
|
Picato |
Ingenol mebutate |
Keratosis, actinic |
Complete |
May 9, 2013 |
January 22, 2014 |
Picato |
Mébutate d'ingénol |
Kératose actinique |
Complete |
May 26, 2014 |
|
Pifeltro |
doravirine |
infection due au VIH-1 |
Active |
November 16, 2018 |
|
Plegridy |
Peginterféron béta-1a |
Sclérose en plaques cyclique |
Complete |
June 26, 2015 |
December 17, 2015 |
Teveten Plus |
Eprosartan mesylate/ hydrochlorothiazide |
Hypertension, Essential |
Complete |
July 8, 2004 |
December 15, 2004 |
Pradaxa |
Dabigatran etexilate |
Thromboembolism (venous), prevention |
Complete |
July 8, 2008 |
January 28, 2009 |
Pradaxa |
Dabigatran etexilate |
Atrial fibrillation prevention of stroke and systemic embolism |
Complete |
October 28, 2010 |
June 22, 2011 |
Pradaxa |
Dabigatran etexilate |
Atrial fibrillation prevention of stroke and systemic embolism |
Cancelled |
May 31, 2010 |
|
Pradaxa |
Dabigatran etexilate |
Atrial fibrillation prevention of stroke and systemic embolism |
Complete |
March 18, 2013 |
July 18, 2013 |
Praluent |
Alirocumab |
Hypercholestérolémie primaire (non-familiale et hétérozygote familiale), dyslipidémie mixte |
Complete |
January 12, 2016 |
July 20, 2016 |
Praxbind |
Idarucizumab (Drug Plan Submission) |
neutralisation de l’effet anticoagulant du dabigatran |
Withdrawn |
May 30, 2016 |
|
Prevymis |
létermovir |
Infection au cytomégalovirus, prophylaxie |
Complete |
December 7, 2017 |
June 20, 2018 |
Prexige |
Lumiracoxib |
Osteoarthritis (Knee) |
Complete |
December 15, 2006 |
July 25, 2007 |
Prezcobix |
Darunavir/cobicistat |
Infection par le VIH |
Complete |
May 22, 2014 |
March 18, 2015 |
Prezista |
Darunavir |
HIV infection |
Complete |
August 29, 2006 |
February 14, 2007 |
Prezista |
Darunavir |
HIV infection (Pediatric) |
Complete |
December 22, 2009 |
June 17, 2010 |
Prezista |
Darunavir |
HIV (treatment naive) |
Complete |
March 27, 2009 |
October 14, 2009 |
Pristiq |
Desvenlafaxine succinate |
Depressive, Major Disorder (MDD) |
Complete |
March 5, 2009 |
September 23, 2009 |
Probuphine |
chlorhydrate de buprénorphine |
le traitement de la dépendance aux opioïdes |
Complete |
December 21, 2017 |
August 22, 2018 |
Procysbi |
bitartrate de cystéamine |
cystinose néphropathique |
Complete |
August 8, 2017 |
January 24, 2018 |
Prolia |
Denosumab (Déposé par un régime d’assurance médicaments) |
Ostéoporose chez les hommes |
Complete |
March 10, 2015 |
September 21, 2015 |
Prolia |
Denosumab |
Osteoporosis, postmenopausal women |
Complete |
August 26, 2010 |
March 30, 2011 |
Prolia |
Dénosumab |
Ostéoporose, femmes postménopausiques |
Complete |
October 26, 2015 |
May 20, 2016 |
Quinsair |
Lévofloxacine |
Fibrose kystique compliquée par des infections pulmonaires chroniques dues à Pseudomas æruginosa |
Complete |
May 31, 2016 |
November 21, 2016 |
Radicava |
édavarone |
sclérose latérale amyotrophique |
Active |
July 5, 2018 |
|
Ralivia |
Tramadol hydrochloride |
Pain |
Complete |
October 29, 2007 |
June 25, 2008 |
RAPAFLO |
Silodosin |
Prostatic Hyperplasia, benign |
Complete |
October 25, 2011 |
April 19, 2012 |
Raptiva |
Efalizumab |
Psoriasis, moderate to severe chronic plaque |
Complete |
October 25, 2005 |
August 24, 2006 |
Raptiva |
Efalizumab |
Psoriasis, moderate to severe chronic plaque |
Complete |
June 19, 2007 |
|
Rasilez |
Aliskiren |
Hypertension |
Complete |
November 30, 2007 |
June 25, 2008 |
Ravicti |
phénylbutyrate de glycérol |
Troubles du cycle de l’urée |
Complete |
August 30, 2016 |
March 21, 2017 |
Rebif |
Interferon beta-1a |
Clinically Isolated Syndrome |
Complete |
March 8, 2013 |
August 15, 2013 |
Relistor |
Methylnaltrexone bromide |
Constipation, Opioid-induced |
Complete |
May 7, 2008 |
January 28, 2009 |
Relpax |
Eletriptan hydrobromide |
Migraine |
Complete |
September 21, 2004 |
March 23, 2005 |
Remicade |
Infliximab |
Ulcerative Colitis |
Complete |
September 29, 2008 |
April 22, 2009 |
Remodulin |
Treprostinil sodium |
Pulmonary arterial hypertension (NYHA Class III and IV patients) |
Complete |
February 24, 2006 |
July 20, 2006 |
Remodulin |
Treprostinil sodium |
Pulmonary arterial hypertension (NYHA Class III and IV patients) |
Complete |
July 14, 2004 |
November 17, 2004 |
Remsima |
Infliximab |
Spondylarthrite ankylosante, psoriasis en plaques, arthrite psoriasique, arthrite rhumatoïde |
Withdrawn |
May 30, 2014 |
|
Renflexis |
infliximab |
arthrite rhumatoïde, spondylarthrite ankylosante, maladie de Crohn chez l’adulte, maladie de Crohn pédiatrique, maladie de Crohn fistuleuse, colite ulcéreuse chez l’adulte, colite ulcéreuse pédiatrique, arthrite psoriasique, psoriasis en plaques |
Complete |
September 5, 2017 |
February 20, 2018 |
Repatha |
Evolocumab |
hyperlipidémie primaire et dyslipidémie mixte |
Complete |
February 17, 2017 |
November 22, 2017 |
Repatha |
Évolocumab |
Hyperlipédémie primaire, dyslipédémie mixte, hypercholestérolémie familiale homozygote |
Complete |
June 30, 2015 |
February 19, 2016 |
Replagal |
Agalsidase alfa |
Fabry Disease |
Complete |
February 19, 2004 |
November 24, 2004 |
Resotran |
Prucalopride |
Constipation, chronic |
Complete |
January 30, 2012 |
July 19, 2012 |
Spiriva Respimat |
Tiotropium bromide |
Chronic Obstructive Pulmonary Disease (COPD) |
Complete |
December 23, 2014 |
July 16, 2015 |
Revatio |
Sildenafil citrate |
Pulmonary arterial hypertension (WHO class II and III) |
Complete |
September 20, 2006 |
February 14, 2007 |
Revestive |
téduglutide |
Syndrome de l’intestin court (SIC) |
Complete |
November 26, 2015 |
July 27, 2016 |
Revolade |
Eltrombopag |
Thrombocytopénie associée à l’hépatite C |
Complete |
March 31, 2014 |
March 18, 2015 |
Revolade |
Eltrombopag olamine |
Thrombocytopenic purpura chronic immune (idiopathic) |
Complete |
April 26, 2011 |
October 24, 2011 |
Rexulti |
Brexpiprazole |
Schizophrénie |
Complete |
February 3, 2017 |
November 22, 2017 |
Reyataz |
Atazanavir |
HIV infection |
Complete |
December 16, 2003 |
May 27, 2004 |
Rituxan |
Rituximab |
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA), remission induction (adults) |
Complete |
February 24, 2012 |
August 16, 2012 |
Rituxan |
Rituximab |
Arthritis, Rheumatoid |
Complete |
June 26, 2006 |
February 14, 2007 |
Rosiver |
Ivermectine |
Rosacée |
Complete |
April 30, 2015 |
November 19, 2015 |
Samsca |
Tolvaptan |
Hyponatremia, non-hypovolemic |
Complete |
July 3, 2012 |
February 13, 2013 |
Saphris |
Asenapine |
Schizophrenia |
Complete |
December 12, 2011 |
June 14, 2012 |
Saphris |
Asenapine |
Bipolar I disorder |
Complete |
December 12, 2011 |
June 14, 2012 |
Sativex |
Delta-9-tetrahydrocannabinol/cannabidiol |
Pain, cancer (adjunctive analgesia to maximum tolerated strong opioids) |
Complete |
August 7, 2007 |
February 20, 2008 |
Sativex |
Delta-9-tetrahydrocannabinol/cannabidiol |
Pain, Neuropathic (adjunctive) in MS. |
Complete |
February 27, 2007 |
September 26, 2007 |
Sebivo |
Telbivudine |
Hepatitis B (chronic) |
Complete |
December 4, 2006 |
September 26, 2007 |
Seebri |
Glycopyrronium bromide |
Chronic Obstructive Pulmonary Disease (COPD), maintenance bronchodilator treatment |
Complete |
November 30, 2012 |
May 15, 2013 |
Segluromet |
ertugliflozine et chlorhydrate de metformine |
Diabète de type 2 |
Complete |
April 30, 2018 |
January 23, 2019 |
Semglee |
Insuline glargine |
Diabète sucré, type 1 et 2 |
Active |
November 14, 2018 |
|
Sensipar |
Cinacalcet hydrochloride |
Secondary hyper-parathyroidism in chronic kidney disease |
Complete |
August 20, 2004 |
March 23, 2005 |
Signifor |
Pasiréotide diaspartate |
maladie de Cushing |
Complete |
February 27, 2014 |
February 24, 2015 |
Siliq |
Brodalumab |
Psoriasis en plaques, modéré ou grave |
Complete |
December 14, 2017 |
June 20, 2018 |
Silkis |
Calcitriol |
Psoriasis, mild to moderate plaque |
Complete |
March 15, 2010 |
September 22, 2010 |
Simbrinza |
Brinzolamide / brimonidine |
Glaucoma and ocular hypertension |
Complete |
November 3, 2014 |
June 17, 2015 |
Simponi |
Golimumab |
Arthritis, Rheumatoid |
Complete |
September 3, 2009 |
March 17, 2010 |
Simponi |
Golimumab |
Ankylosing spondylitis |
Complete |
September 3, 2009 |
March 17, 2010 |
Simponi |
Golimumab |
Ulcerative colitis |
Complete |
July 12, 2013 |
March 19, 2014 |
Simponi |
Golimumab |
Arthritis, psoriatic |
Complete |
September 3, 2009 |
March 17, 2010 |
Sivextro |
Tedizolid phosphate |
Acute bacterial skin and skin structure infections |
Withdrawn |
January 16, 2015 |
|
Soliqua |
lixisénatide et insuline glargine |
Diabète de type 2 |
Complete |
May 18, 2018 |
December 24, 2018 |
Soliris |
Eculizumab |
Hemolytic Uremic Syndrome, Atypical |
Complete |
January 7, 2013 |
July 18, 2013 |
Soliris |
Eculizumab |
Paroxysmal nocturnal hemoglobinuria (PNH) |
Complete |
September 18, 2009 |
February 18, 2010 |
Soliris |
Éculizumab |
syndrome hémolytique et urémique, atypique |
Complete |
February 9, 2015 |
|
Somavert |
Pegvisomant |
acromegaly |
Complete |
January 25, 2006 |
August 2, 2006 |
Sovaldi |
sofosbuvir |
Hépatite C, chronique |
Complete |
January 6, 2016 |
May 18, 2016 |
Sovaldi |
Sofosbuvir |
Hepatitis C, chronic |
Complete |
October 1, 2013 |
August 18, 2014 |
Spinraza |
nusinersen |
amyotrophie spinale |
Complete |
June 28, 2017 |
December 22, 2017 |
Spinraza |
Nusinersen |
Amyotrophie spinale |
Active |
July 24, 2018 |
|
Spriafil |
Posaconazole |
Aspergillus and Candida infections |
Complete |
May 24, 2007 |
January 30, 2008 |
Stalevo |
Carbidopa, levodopa and entacapone |
Parkinsons Disease |
Complete |
April 15, 2008 |
October 16, 2008 |
Steglatro |
|
Diabète de type 2 |
Complete |
April 30, 2018 |
January 23, 2019 |
Stelara |
Ustekinumab |
Psoriasis |
Complete |
January 7, 2009 |
June 17, 2009 |
Stelara |
ustekinumab |
Maladie de Crohn |
Complete |
September 12, 2016 |
March 21, 2017 |
Stelara |
Ustekinumab |
Arthritis, Psoriatic |
Complete |
October 30, 2013 |
October 20, 2014 |
Strattera |
Atomoxetine hydrochloride |
Attention deficit hyperactivity disorder |
Complete |
September 25, 2006 |
|
Strattera |
Atomoxetine hydrochloride |
Attention deficit hyperactivity disorder |
Complete |
January 25, 2005 |
September 28, 2005 |
Strensiq |
Asfotase alfa |
Hypophosphatasie, Durant l’enfance |
Complete |
August 21, 2015 |
March 23, 2016 |
Stribild |
Elvitegravir/ Cobicistat/ Emtricitabine/ Tenofovir Disoproxil Fumarate |
HIV-1 infection |
Complete |
November 30, 2012 |
May 15, 2013 |
Sublinox |
Zolpidem tartrate |
Insomnia, short-term treatment |
Complete |
March 7, 2013 |
September 25, 2013 |
Sublocade |
Buprénorphine |
Traitement du trouble de consommation d'opioïdes |
Active |
December 20, 2018 |
|
Suboxone |
Buprenorphine/naloxone |
Opioid drug dependence (Substitution treatment) |
Complete |
March 6, 2008 |
September 24, 2008 |
Sunvepra |
Asunaprévir |
Hépatite C chronique |
Complete |
February 13, 2015 |
July 20, 2016 |
Sutent |
Sunitinib |
Gastrointestinal stromal tumour (GIST) |
Complete |
July 20, 2006 |
March 28, 2007 |
Sutent |
Sunitinib malate |
Cancer, Metastatic renal cell carcinoma |
Complete |
September 20, 2006 |
April 26, 2007 |
Symtuza |
Darunavir/cobicistat/emtricitabine/ténofovir alafénamide |
infection par le VIH-1 |
Complete |
December 22, 2017 |
July 25, 2018 |
Synjardy |
Empagliflozine et metformine |
Diabète de type 2 |
Complete |
April 29, 2016 |
October 25, 2016 |
Taltz |
Ixekizumab |
Psoriasis en plaques modéré à sévère |
Complete |
March 23, 2016 |
October 25, 2016 |
Taltz |
ixékizumab |
Arthrite psoriasique évolutive |
Complete |
February 20, 2018 |
August 21, 2018 |
Tarceva |
Erlotinib |
Cancer, Lung , non-small cell |
Complete |
July 19, 2005 |
December 7, 2005 |
Targin |
Oxycodone HCI / naloxone HCI |
Pain, Moderate to severe and relief of opioid-induced constipation |
Complete |
July 5, 2011 |
January 25, 2012 |
Targin |
Oxycodone / naloxone |
Pain, Moderate to severe and relief of opioid-induced constipation |
Cancelled |
November 30, 2010 |
|
TBC |
propionate d’halobétasol et tazarotène |
Psoriasis en plaques de modéré à grave |
Received |
February 4, 2019 |
|
TBC |
risankizumab |
Le psoriasis en plaques modété à grave |
Active |
October 22, 2018 |
|
TBC |
filgrastim |
Prévention ou le traitement de la neutropénie dans différentes indications |
Active |
November 1, 2018 |
|
TBC |
Darunavir / cobicistat |
infection par le VIH |
Withdrawn |
April 4, 2014 |
|
TBC |
érénumab |
Migraine |
En attente |
|
|
TBC |
dolutégravir/lamivudine |
Infection par le VIH-1 |
En attente |
|
|
TBC |
filgrastim |
Neutropénie, mobilisation des cellules sanguines (différentes indications) |
En attente |
|
|
Tecfidera |
Dimethyl fumarate |
Multiple Sclerosis, relapsing |
Complete |
February 4, 2013 |
September 25, 2013 |
Technivie |
ombitasvir/ paritaprévir/ ritonavir |
hépatite C chronique, VHC de génotype 4 |
Complete |
September 4, 2015 |
March 18, 2016 |
Tegsedi |
inotersen |
amylose héréditaire liée à la transthyrétine |
En attente |
|
|
Telzir |
Fosamprenavir calcium |
HIV infection |
Complete |
January 24, 2005 |
June 16, 2005 |
Thelin |
Sitaxsentan sodium |
Pulmonary arterial hypertension (WHO class II and III) |
Complete |
May 5, 2008 |
January 28, 2009 |
Thelin |
Sitaxsentan sodium |
Pulmonary arterial hypertension (WHO class II and III) |
Complete |
June 22, 2007 |
January 30, 2008 |
Tivicay |
Dolutegravir |
HIV infection |
Complete |
October 18, 2013 |
August 18, 2014 |
Toctino |
Alitretinoin |
Eczema |
Complete |
May 6, 2011 |
October 24, 2011 |
Toviaz |
Fesoterodine fumarate |
Bladder, overactive |
Complete |
April 27, 2012 |
October 18, 2012 |
Trajenta |
Linagliptin |
Diabetes mellitus, Type 2 |
Complete |
August 23, 2011 |
February 15, 2012 |
Tramacet |
Tramadol hydrochloride /acetaminophen |
Acute pain |
Complete |
October 2, 2006 |
May 17, 2007 |
Trelstar |
Triptorelin pamoate |
Cancer, prostate |
Complete |
February 27, 2006 |
July 20, 2006 |
Tremfya |
|
Psoriasis en plaques de modéré à sévère |
Complete |
August 25, 2017 |
February 21, 2018 |
Tresiba |
insuline dégludec |
Diabète sucré, types 1 et 2 |
Complete |
May 31, 2017 |
November 20, 2017 |
Tridural |
Tramadol hydrochloride |
Pain |
Complete |
November 29, 2007 |
April 17, 2008 |
Trintellix |
Vortioxetine |
trouble dépressif majeur |
Withdrawn |
October 31, 2014 |
|
Triumeq |
Dolutegravir / abacavir / lamivudine |
HIV Infection |
Complete |
July 31, 2014 |
April 17, 2015 |
Trosec |
Trospium chloride |
Bladder, overactive |
Complete |
March 24, 2006 |
August 24, 2006 |
Trulicity |
dulaglutide |
Diabète sucré, type 2 |
Complete |
December 22, 2015 |
June 16, 2016 |
Truvada |
Emtricitabine/tenofovir disoproxil fumarate |
HIV infection |
Complete |
May 29, 2006 |
October 25, 2006 |
Truvada |
Emtricitabine/tenofovir disoproxil fumarate |
HIV infection |
Complete |
July 7, 2008 |
December 17, 2008 |
Truvada |
Emtricitabine/fumarate de ténofovir disoproxil |
Infection par le VIH, prophylaxie préexposition |
Complete |
March 3, 2016 |
August 24, 2016 |
Twynsta |
Telmisartan/ Amlodipine |
Hypertension, Essential |
Complete |
August 23, 2011 |
December 16, 2011 |
Twynsta |
Telmisartan / Amlodipine |
Essential hypertension |
Cancelled |
July 9, 2010 |
|
Tysabri |
Natalizumab |
Multiple Sclerosis, relapsing-remitting |
Complete |
May 6, 2008 |
February 25, 2009 |
Tysabri |
Natalizumab |
Multiple Sclerosis, relapsing-remitting |
Complete |
October 26, 2006 |
April 26, 2007 |
Uloric |
Febuxostat |
Gout |
Complete |
October 27, 2010 |
April 25, 2011 |
Uptravi |
Sélexipag |
Hypertension artérielle pulmonaire (OMS) de classe II et III |
Complete |
March 31, 2016 |
October 28, 2016 |
Vantas |
Histrelin acetate |
Cancer, prostate |
Complete |
September 20, 2006 |
April 26, 2007 |
Velphoro |
oxyhydroxyde sucro-ferrique |
hyperphosphatémie, insuffisance rénale terminale |
Complete |
June 12, 2018 |
January 2, 2019 |
Vemlidy |
ténofovir alafénamide |
Hépatite B chronique |
Complete |
September 28, 2017 |
March 26, 2018 |
Vesicare |
Solifenacin succinate |
Bladder, overactive |
Complete |
July 24, 2006 |
January 24, 2007 |
Vesicare |
Solifenacin succinate |
Bladder, overactive |
Complete |
January 5, 2009 |
June 17, 2009 |
VesiFlow |
Succinate de solifénacine / chlorhydrate de tamsulosine |
hyperplasie bénigne de la prostate (HBP)-associée à des symptômes des voies urinaires inférieures |
Withdrawn |
April 6, 2015 |
|
VFEND |
Voriconazole |
Candidemia |
Complete |
March 24, 2006 |
October 25, 2006 |
VFEND |
Voriconazole |
Aspergillosis, Invasive |
Complete |
October 25, 2004 |
April 14, 2005 |
VFEND |
Voriconazole |
Aspergillosis, Invasive |
Withdrawn |
August 24, 2004 |
|
Viacoram |
perindopril arginine / bésylate d’amlodipine |
Hypertension essentielle |
Complete |
May 2, 2016 |
October 26, 2016 |
Viberzi |
éluxadoline |
Syndrome du côlon irritable avec diarrhée |
Complete |
February 23, 2018 |
August 24, 2018 |
Victoza |
Liraglutide |
Diabetes mellitus, Type 2 |
Complete |
November 29, 2010 |
September 28, 2011 |
Victoza |
Liraglutide |
Diabète, Type 2 |
Withdrawn |
October 20, 2016 |
|
Victrelis |
Boceprevir |
Hepatitis C, chronic |
Complete |
May 3, 2011 |
October 24, 2011 |
Victrelis |
Boceprevir |
|
Complete |
December 21, 2012 |
June 13, 2013 |
Victrelis |
Boceprevir |
Hepatitis C infection, chronic |
Complete |
February 19, 2013 |
June 13, 2013 |
Vimizim |
élosulfase alfa |
Mucopolysaccharidose IVA (syndrome de Morquio) |
Complete |
August 5, 2014 |
March 25, 2015 |
Vimizim |
Élosulfase alfa |
Mucopolysaccharidose IVA (Syndrome de Morquio A) |
Complete |
November 10, 2015 |
May 20, 2016 |
Vimpat |
Lacosamide |
Epilepsy, partial onset seizures (POS) |
Complete |
October 25, 2010 |
April 25, 2011 |
Viread |
Tenofovir disoproxil fumarate |
HIV infection |
Complete |
February 23, 2004 |
August 25, 2004 |
Viread |
Tenofovir disoproxil fumarate |
HIV infection |
Complete |
August 11, 2005 |
March 15, 2006 |
Viread |
Tenofovir disoproxil fumarate |
Hepatitis B (chronic) |
Complete |
October 2, 2008 |
March 18, 2009 |
Viread |
Tenofovir disoproxil fumarate |
HIV infection |
Complete |
July 7, 2008 |
|
Visanne |
Dienogest |
Pelvic pain associated with endometriosis |
Complete |
October 18, 2011 |
April 19, 2012 |
Volibris |
Ambrisentan |
Pulmonary arterial hypertension (WHO class II and III) |
Complete |
July 9, 2008 |
December 17, 2008 |
Vosevi |
sofosbuvir/velpatasvir/voxilaprévir |
Hépatite C chronique |
Complete |
July 28, 2017 |
January 23, 2018 |
VPRIV |
Velaglucerase alfa |
Gaucher Disease |
Complete |
October 28, 2010 |
April 25, 2011 |
Vyvanse |
Lisdexamfetamine dimesylate |
Attention deficit hyperactivity disorder |
Complete |
July 10, 2009 |
December 18, 2009 |
Vyzulta |
latanoprostène bunod |
Glaucome à angle ouvert ou hypertension oculaire |
Active |
November 23, 2018 |
|
Xarelto |
Rivaroxaban |
Thromboembolic events (venous), pulmonary embolism |
Complete |
May 6, 2013 |
March 26, 2014 |
Xarelto |
Rivaroxaban |
Thromboembolism (venous), prevention |
Complete |
May 7, 2008 |
December 17, 2008 |
Xarelto |
Rivaroxaban |
Thromboembolism (venous) prevention |
Complete |
June 24, 2011 |
|
Xarelto |
rivaroxaban |
Prévention de l’accident vasculaire cérébral et d'évènements cardiovasculaires causés par la coronopathie ou la maladie artérielle périphérique |
Complete |
May 24, 2018 |
November 20, 2018 |
Xarelto |
Rivaroxaban |
Deep-Vein Thrombosis (treatment), without Symptomatic Pulmonary Embolism |
Complete |
February 27, 2012 |
August 16, 2012 |
Xarelto |
Rivaroxaban |
Atrial fibrillation, stroke prevention |
Complete |
October 21, 2011 |
April 19, 2012 |
Xarelto |
Rivaroxaban |
Deep-Vein Thrombosis (treatment), without Symptomatic Pulmonary Embolism |
Complete |
October 10, 2012 |
|
Xarelto |
Rivaroxaban |
stroke prevention in patients with atrial fibrillation. |
Complete |
March 18, 2013 |
July 18, 2013 |
Xeljanz |
Tofacitinib |
Arthrite rhumatoïde |
Complete |
May 5, 2014 |
April 17, 2015 |
Xeljanz |
Tofacitinib |
Polyarthrite psoriasique |
En attente |
|
|
Xeljanz |
tofacitinib |
|
Active |
June 27, 2018 |
|
Xeomin |
Clostridium botulinum neurotoxin type A, free from complexing proteins |
Blepharospasm |
Complete |
June 12, 2009 |
December 16, 2009 |
Xeomin |
Clostridium botulinum neurotoxin type A, free from complexing proteins |
Cervical Dystonia |
Complete |
June 12, 2009 |
December 16, 2009 |
Xeomin |
Clostridium botulinum neurotoxin type A, free from complexing proteins |
Spasticity, Post-stroke |
Complete |
June 12, 2009 |
December 16, 2009 |
Xermelo |
télotristat |
syndrome carcinoïde |
Active |
September 27, 2018 |
|
Xgeva |
Denosumab (Drug Plan Submission) |
Prévention des complications squelettiques causées par des métastases osseuses découlant du cancer du sein |
Complete |
July 31, 2015 |
February 25, 2016 |
Xgeva |
Denosumab (Drug Plan Submission) |
Prevention of skeletal-related events due to bone metastases from other solid tumors (excluding breast and prostate cancer), including non-small cell lung cancer |
Complete |
July 31, 2015 |
March 23, 2016 |
XGEVA |
Denosumab |
Prevention of skeletal-related events due to bone metastases from solid tumours |
Complete |
June 6, 2011 |
November 16, 2011 |
Xiaflex |
Collagenase clostridium histolyticum |
Dupuytren’s contracture with a palpable cord |
Complete |
August 30, 2012 |
March 27, 2013 |
XigDuo |
dapagliflozin/metformin hydrochloride |
Diabète sucré de type 2 |
Active |
January 7, 2016 |
July 20, 2016 |
Zytram XL |
Tramadol hydrochloride |
Pain, acute |
Withdrawn |
November 3, 2006 |
|
Zytram XL |
Tramadol hydrochloride |
Pain, acute |
Complete |
March 15, 2007 |
September 26, 2007 |
Xolair |
Omalizumab |
Asthma, severe persistent |
Suspended |
April 18, 2005 |
|
Xolair |
Omalizumab |
Asthma, severe persistent |
Complete |
October 13, 2005 |
March 7, 2006 |
Xolair |
Omalizumab (Déposé par un régime d’assurance médicaments) |
Asthme grave persistent |
Complete |
November 18, 2015 |
May 18, 2016 |
Xolair |
Omalizumab |
Urticaire, idiopathique chronique |
Complete |
September 22, 2014 |
May 7, 2015 |
Xultophy |
insuline dégludec et liraglutide |
Diabète sucré de type 2 |
Active |
January 30, 2019 |
|
Xyrem |
Sodium oxybate |
Narcolepsy |
Withdrawn |
August 29, 2007 |
|
Xyrem |
Sodium oxybate |
Narcolepsy |
Complete |
July 9, 2008 |
January 28, 2009 |
Yasmin |
Drospirenone /ethinyl estradiol |
Contraceptive, oral |
Complete |
January 20, 2005 |
June 16, 2005 |
Zavesca |
Miglustat |
Gaucher disease |
Complete |
May 13, 2004 |
November 24, 2004 |
Zaxine |
Rifaximine |
Encéphalopathie, Hépatique |
Complete |
August 5, 2014 |
April 16, 2015 |
Zeldox |
Ziprasidone hydrochloride |
Schizophrenia and related psychotic disorders |
Complete |
January 10, 2008 |
August 14, 2008 |
Zenhale |
Mometasone/formoterol |
Asthma maintenance (adults, children 12 or older) |
Complete |
June 6, 2012 |
December 19, 2012 |
Zepatier |
Elbasvir / Grazoprévir |
Hépatite C chronique |
Complete |
October 27, 2015 |
May 19, 2016 |
Zinbryta |
Daclizumab bêta |
Sclérose en plaques cyclique |
Complete |
December 20, 2016 |
June 20, 2017 |
|
|
|
|
|
|